COMPLEMENT-MEDIATED KIDNEY DISEASE
Clinical trials for COMPLEMENT-MEDIATED KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new COMPLEMENT-MEDIATED KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for COMPLEMENT-MEDIATED KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human doses given for new PNH pill
Knowledge-focused Not yet recruitingThis is the first time a new oral drug called CMS-D017 is being tested in people. The study aims to check its safety and see how the body processes it in healthy Chinese adult volunteers. It will test single and multiple doses, comparing them to a placebo. The drug is being devel…
Matched conditions: COMPLEMENT-MEDIATED KIDNEY DISEASE
Phase: PHASE1 • Sponsor: Shenzhen Kangzhe Biotechnology Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
First Real-World look at new kidney disease pill
Knowledge-focused Not yet recruitingThis study will observe 83 adults with a rare kidney disease called C3 glomerulopathy (C3G) who are already taking the approved drug iptacopan. Researchers will review patients' medical records from before and after starting the medication to understand who gets treated and how t…
Matched conditions: COMPLEMENT-MEDIATED KIDNEY DISEASE
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC